Testopel ® vs. Generic Testosterone Pellets.

• Status: Recruiting
• Trial end date: 2022-03-03

Summary

The purpose of this study is to evaluate changes in vascular parameters in subjects receiving Testopel 75mg (one time) versus subjects receiving Compounded Testosterone pellets 100mg (one time) versus subjects receiving Compounded Testosterone pellets 200mg (one time) to participant with clinical hypogonadism.

• Phase: Phase 3

Details

• Lead Sponsor: University of Miami
• Collaborator: Empower Pharmacy
• Treatments: Methyltestosterone; Testosterone; Testosterone 17 beta-cypionate; Testosterone enanthate; Testosterone undecanoate